Coagulation factor xiii

Corifact 1250

1250 UNIT / VIAL Powder For SolutionCanadaMarketedAuthorised 3 Apr 2014

In other countries

The same active substances on other registers, the same brand first.

Cluvot 250 Ui, Polvo y Disolvente Para Solucion Inyectable O PerfusionSpain · 200-300 UI · polvo y disolvente para solución inyectable y para perfusión · Csl Behring GmbhSame substance
Cluvot 1250 Ui, Polvo y Disolvente Para Solucion Inyectable O PerfusionSpain · 1000-1600 UI · polvo y disolvente para solución inyectable · Csl Behring GmbhSame substance
CluviatItaly · Polvere e solvente per soluzione iniettabile/ per infusione · CSL Behring GMBHSame substance
Cluvot 1250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie · CSL Behring GmbHSame substance
Cluvot 250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie · CSL Behring GmbH

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Coagulation factor xiii

Corifact 1250

1250 UNIT / VIAL Powder For SolutionCanadaMarketedAuthorised 3 Apr 2014

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Coagulation factor xiii
Strength: 1250 UNIT / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 3 Apr 2014
Registration: DIN 02418746
Marketing authorisation holder: CSL Behring Canada INC
ATC code: B02BD07
Group: Blood and blood-forming organs
Supply: SCHEDULE D